Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CEBPA |
| Upstream (Parents) |
|---|
| (<<) CDH3 → CEBPA |
| (<<) CISH → CEBPA |
| (<<) DAZAP2 → CEBPA |
| (<<) DDX18 → CEBPA |
| (<<) FOXC2 → CEBPA |
| (<<) GBP2 → CEBPA |
| (<<) HLA-DOA → CEBPA |
| (<<) IL1B → CEBPA |
| (<<) IL6 → CEBPA |
| (<<) KLF2 → CEBPA |
| (<<) LTA4H → CEBPA |
| (<<) MKNK2 → CEBPA |
| (<<) MPP1 → CEBPA |
| (<<) PALM → CEBPA |
| (<<) PLOD2 → CEBPA |
| (<<) PRKCH → CEBPA |
| (<<) PTPN12 → CEBPA |
| (<<) RHOB → CEBPA |
| (<<) WNT3 → CEBPA |
| (<<) ZFP36 → CEBPA |
| Downstream (Children) |
|---|
| CEBPA → BMP2 (>>) |
| CEBPA → CLCA4 (>>) |
| CEBPA → CXADR (>>) |
| CEBPA → ERRFI1 (>>) |
| CEBPA → HS3ST1 (>>) |
| CEBPA → JAG1 (>>) |
| CEBPA → KCNK1 (>>) |
| CEBPA → KRT1 (>>) |
| CEBPA → LEMD1 (>>) |
| CEBPA → PLA2G4A (>>) |
| CEBPA → PTGS2 (>>) |
| CEBPA → PTK2 (>>) |
| CEBPA → SLPI (>>) |
| CEBPA → VEGFA (>>) |
